摘要Background:The molecular mechanisms of Shenxianshengmai (SXSM),a traditional Chinese medicine,on bradycardia have been incompletely understood.The study tried to investigate the gene expression profile and proteomics of bradycardia rabbits' hearts after SXSM treatment.Methods:Twenty-four adult rabbits were randomly assigned in four groups:sham,model,model plus SXSM treatment,and sham plus SXSM treatment groups.Heart rate was recorded in all rabbits.Then,total RNA of atria and proteins of ventricle were isolated and quantified,respectively.Gene expression profiling was conducted by gene expression chip,and quantitative real-time reverse transcriptionpolymerase chain reaction (RT-PCR) was performed to confirm the results of gene expression chip.We used isobaric tags for elative and absolute quantitation and Western blotting to identify altered proteins after SXSM treatment.Results:There was a constant decrease in the mean heart rate (32％,from 238 ± 6 beats/min to 149 ± 12 beats/min) after six weeks in model compared with that in sham group.This effect was partially reversed by 4-week SXSM treatment.Complementary DNA microarray demonstrated that the increased acetylcholinesterase and reduced nicotinic receptor were take responsibility for the increased heart rate.In addition,proteins involved in calcium handling and signaling were affected by SXSM treatment.Real-time RT-PCR verified the results from gene chip.Results from proteomics demonstrated that SXSM enhanced oxidative phosphorylation and tricarboxylic acid (TCA) cycle in ventricular myocardium to improve ATP generation.Conclusions:Long-term SXSM stimulates sympathetic transmission by increasing the expression of acetylcholinesterase and reduces the expression of nicotinic receptor to increase heart rate.SXSM also restored the calcium handling genes and altered genes involved in signaling.In addition,SXSM improves the ATP supply of ventricular myocardium by increasing proteins involved in TCA cycle and oxidation-respiratory chain.